Antiretroviral News and Research

RSS

Ugandan President calls for public-private partnership to fight HIV/AIDS during U.S. meeting

Ugandan President Yoweri Museveni last week during a meeting in Washington, D.C., with representatives from the African Diplomatic Corps, U.S. government officials and representatives from the health care industry called for a public-private partnership to fight HIV/AIDS in Uganda, Uganda's Monitor reports.

6 Nov 2007

Global Fund, World Bank provide Malawi with $48.5 million to expand HIV/AIDS services, commission says

Malawi's National AIDS Commission in a statement issued Thursday announced that it has received $48.5 million from the Global Fund To Fight AIDS, Tuberculosis and Malaria and the World Bank to expand HIV/AIDS services in the country up to December, Xinhua News Agency reports.

5 Nov 2007

Testing delays cause severe AIDS complications

Despite the availability of life-saving antiretroviral treatment, people infected with HIV (human immunodeficiency virus) continue to die and suffer from complications of AIDS, mainly due to delayed diagnosis and initiation of treatment.

5 Nov 2007

TB vaccine can be a killer for babies with HIV

Experts in South Africa say a vaccine which was meant to protect children in developing countries from tuberculosis (TB)may in fact be killing them.

4 Nov 2007

New evidence that psychological factors play a role in disease progression

Even though effective drug cocktails have improved the outlook for many patients with HIV, disease progression, including the time from AIDS onset to death, varies widely from patient to patient.

2 Nov 2007

Pharmacies, drug wholesaler file lawsuit against Abbott over price of antiretroviral Norvir

Four pharmacy chains and one pharmaceutical wholesaler on Monday filed a lawsuit against Abbott Laboratories over the price of its antiretroviral drug Norvir, the Wall Street Journal reports.

30 Oct 2007

Some HIV-positive people taking longer to initiate treatment

Some HIV-positive people in key demographic groups do not seek treatment any sooner than they did in the past, and some people now take longer to initiate treatment, according to a study published in the Nov. 15 issue of Clinical Infectious Diseases, United Press International reports (United Press International, 10/27).

30 Oct 2007

Zimbabwe in line to reach antiretroviral treatment target, health official says

Zimbabwe could meet its target of providing 140,000 HIV-positive people with access to no-cost antiretroviral drugs by the end of the year, Owen Mugurungi, head of the Zimbabwean government's HIV/AIDS unit, said on Tuesday at a two-day workshop on drug access issues in the country, the Herald/AllAfrica.com reports (Herald/AllAfrica.com, 10/26).

29 Oct 2007

New model of HIV dynamics

The emergence of drug resistant forms of HIV often underlies the failure of current antiretroviral therapies for HIV infection.

28 Oct 2007

HIV patients are actually sicker when they begin therapy

It was hoped that as HIV treatment improved and as HIV-related public health initiatives encouraged people to be tested for the disease and seek care, that HIV-infected patients would seek care quickly.

25 Oct 2007

HIV combination antiretroviral drug therapy key to saving the lives of African children

Letting nurses and other trained health care workers deliver that therapy and monitor patients, especially when doctors are in short supply, is just as important to saving lives, according to a new study by the University of Alabama at Birmingham (UAB).

24 Oct 2007

Critical need for earlier diagnosis and referral of HIV-infected children in Africa

Care provided by nurses and other clinicians in primary health care settings in sub-Saharan Africa can result in good outcomes for children with HIV infection.

22 Oct 2007

Good outcomes possible for HIV-infected children in Africa enrolled in pediatric treatment programs

Care provided by nurses and other clinicians in primary health care settings in sub-Saharan Africa can result in good outcomes for children with HIV infection.

22 Oct 2007

Free medications ensure anti-HIV drugs are taken in Africa

HIV-infected patients in the African country of Tanzania were more likely to stop taking their medications and to fail treatment if they had to pay for the drugs themselves.

22 Oct 2007

Fight against HIV needs local scientists

Scientists from developing countries are vitally important in the fight against HIV and they must be given the proper resources to conduct their work, according to a new commentary published today in the journal Nature Immunology.

22 Oct 2007

Scientists discover how HIV evolves

University of Florida scientists have discovered how HIV evolves over the course of a person's lifetime into a more deadly form that heralds the onset of full-blown AIDS.

17 Oct 2007

FDA approves raltegravir new HIV drug

The U.S. Food and Drug Administration (FDA) has approved raltegravir tablets for treatment of Human Immunodeficiency Virus (HIV)-1 infection in combination with other antiretroviral agents in treatment-experienced adult patients who have evidence of viral replication and HIV-1 strains resistant to multiple antiretroviral agents.

17 Oct 2007

HAART stops brain damage caused by HIV

A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a study published in the October 9, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.

9 Oct 2007

microRNAs may be key to HIV's ability to hide, evade drugs

Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system.

1 Oct 2007

Promoting safety of medicines for children

The lack of thorough and reliable clinical data on the way medicines affect children requires strengthened safety monitoring and vigilance of medicinal products.

24 Sep 2007